Catalyst Pharmaceuticals, Inc. (CPRX)
22.79
+0.46
(+2.06%)
USD |
NASDAQ |
Mar 20, 16:00
22.90
+0.11
(+0.48%)
After-Hours: 20:00
Catalyst Pharmaceuticals Research and Development Expense (Quarterly) : 1.807M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 12.26M |
| ADMA Biologics, Inc. | 1.376M |
| Assertio Holdings, Inc. | 0.486M |
| United Therapeutics Corp. | 139.50M |
| Ionis Pharmaceuticals, Inc. | 279.36M |